Clotting activation after transjugular intrahepatic portosystemic stent shunt

Thrombosis and Haemostasis

Volumn 81, Issue 5, 1999, Pages 711-714

  Basili, Stefania ^b   Merli, Manuela ^c   Ferro, Domenico ^a   Lionetti, Raffaella ^c   Rossi, Elisabetta ^a   Riggio, Oliviero ^c   Valeriano, Valentina ^c   Capocaccia, Livio ^c   Violi, Francesco ^a,d  

^a Universitd degli Studi di Roma   (Italy)

^b Dipartimento di Fisiopatologia Medica   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; PERIPHERAL CIRCULATION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS;

EID: 0032915429     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614559     Document Type: Article

References (22)

1. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, Berger E, Blum V, Gabelmann A, Havenstein KH, Langer M, Gerok W. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Eng J Med 1994; 330: 165-71.
2. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7.
3. Bataller R, Arroyo V, Gines P. Management of ascites in cirrhosis. J Gastroenterol Hepatol 1997; 12: 723-33.
4. Marshall JB, King PD. Transjugular intrahepatic portosystemic shunt or sclerotherapy: which would you choose? Ann Intern Med 1998; 128: 321-2.
5. Stanley AJ, Hayes PC. Portal hypertension and variceal haemorrhage. Lancet 1997; 350: 1235-9.
6. Lind CD, Malisch TW, Chong WK, Richard WO, Pinson CW, Meranze SG, Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gatroenterology 1994; 106: 1277-83.
7. Freedman AM, Sanyal AJ, Tisnado J, Cole PE, Shiffman ML, Luketic VA, Purdum PP, Darcy MD, Posner MP. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics 1993; 13: 1185-210
8. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3rd, Shiffman ML, De-Meo J, Cole PE, Tisnado J. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-98.
9. Shiffman ML, Cole PE. Complications of implantation. In: Conn HO, Palmaz J, Rosch J, Rossle M, Eds. TIPS: Transjugular Intrahepatic Porto-Systemic Stent-Shunts. New York: Igaku-Shoin Medical Publishers; 1996: 249-66.
10. Saxon RR, Barton RE, Keller FS, Rosch J. Stenosis and occlusion after TIPS: prevention and correction. In: Conn HO, Palmaz J, Rosch J, Rossle M, Eds. TIPS: Transjugular Intrahepatic Porto-Systemic Stent-Shunts. New York: Igaku-Shoin Medical Publishers; 1996: 267-80.
11. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1991; 2: 549-56.
12. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1993; 4 (6): 779-86.
13. Saxon RR, Timmermans HA, Uchida BT, Petersen BD, Benner KG, Rabkin J, Keller FS. Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study. J Vasc Interv Radiol 1997; 8: 539-48
14. Sauer P, Theilmann L, Herrmann S, Bruckner T, Roeren T, Richter G, Stremmel W, Stiehl A. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology 1996; 24: 1433-6
15. Shiffman ML. Can anticoagulation enhance TIPS patency? Hepatology 1996; 24: 1533-5
16. Pugh RNH, Murray-Lyon IM, Dawson JL. Transaction of oesophagus for bleeding oesophagus varices. Br J Surg 1973; 60: 646-9.
17. Merli M, Salerno F, Riggio O, De Franchis R, Fiaccadori F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998; 27: 48-53.
18. Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109: 531-9.
19. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Blackwell scientific Publication, Oxford (UK) 1990; pp 200-15.
20. Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 1983; 50: 529-35.
21. Van Deventer SJH, Buller HR, Ten Gate JW, Aarden LA, Hack Ce, Sturk A. Experimental endotoxemia in human: analysis of cytokine release and coagulation fibrinolytic and complement pathways. Blood 1990; 12: 2520-6.
22. Violi F, Ferro D, Basili S, Lionetti R, Rossi E, Merli M, Riggio O, Bezzi M, Capocaccia L. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 1997; 77: 44-7.